Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi

Tülay YANIK (Orta Doğu Teknik Üniversitesi, Fen Edebiyat Fakültesi, Biyoloji Bölümü, Ankara, Türkiye)
0 0

Proje Grubu: TBAG Sayfa Sayısı: 35 Proje No: 111T449 Proje Bitiş Tarihi: 15.10.2013 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi

Öz:
-
Anahtar Kelime:

Erişim Türü: Erişime Açık
  • Woronowicz, A., H. Koshimizu, S.Y. Chang, N.X. Cawley, J.M. Hill, R.M. Rodriguiz, D. Abebe, C. Dorfman, V. Senatorov, A. Zhou, Z.G. Xiong, W.C. Wetsel, and Y.P. Loh, 2008. Absence of carboxypeptidase E leads to adult hippocampal neuronal degeneration and memory deficits. Hippocampus.e-published.
  • Gusella, J.F., N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, P.C. Watkins, K. Ottina, M.R. Wallace, A.Y. Sakaguchi, and et al., 1983. A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 306(5940): p. 234-8.
  • Koide, R., T. Ikeuchi, O. Onodera, H. Tanaka, S. Igarashi, K. Endo, H. Takahashi, R. Kondo, A. Ishikawa, T. Hayashi, and et al., 1994. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet, 6(1): p. 9-13.
  • Nagafuchi, S., H. Yanagisawa, E. Ohsaki, T. Shirayama, K. Tadokoro, T. Inoue, and M. Yamada, 1994. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat Genet, 8(2): p. 177-82.
  • Fischbeck, K.H., A. Lieberman, C.K. Bailey, A. Abel, and D.E. Merry, 1999. Androgen receptor mutation in Kennedy's disease. Philos Trans R Soc Lond B Biol Sci, 354(1386): p. 1075-8.
  • Holmes, S.E., E. O'Hearn, A. Rosenblatt, C. Callahan, H.S. Hwang, R.G. Ingersoll-Ashworth, A. Fleisher, G. Stevanin, A. Brice, N.T. Potter, C.A. Ross, and R.L. Margolis, 2001. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet, 29(4): p. 377-8.
  • Lehmann, D.J., H.T. Butler, D.R. Warden, M. Combrinck, E. King, J.A. Nicoll, M.M. Budge, C.A. de Jager, E. Hogervorst, M.M. Esiri, J. Ragoussis, and A.D. Smith, 2003. Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men. Neurosci Lett, 340(2): p. 87-90.
  • Jan, L., Y. Jan, and M. Brownfield, Peptidergic transmitters in synaptic boutons of sympathetic ganglia, in Nature. 1980. p. 380-382.
  • Aronin, N., M. Difiglia, and S. Leeman, Brain peptides, B.M. Krieger DT, and Martin JB, Editor. 1983, Wiley and Sons: New York.
  • Barker, J. and H. Gainer, Peptide reguation of bursting pacemaker activity in a molluscan neuroseretory cell, in Science. 1974. p. 1371-1373.
  • Gilles, G., E. Kinton, and P. Lowry, Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin, in Nature. 1982. p. 355-357.
  • Radulovic, J., A. Ruhmann, T. Liepold, and J. Spiess, 1999. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci, 19(12): p. 5016-25.
  • Verhaagen, J., P. Edwards, F. Jennekens, P. Schotman, and W. Gispen, 1986. Alpha-melanocyte-stimulating hormone stimulates the outgrowth of myelinated nerve fibers after peripheral nerve crush. Journal of Experimental Biology, 92(2): p. 415-454.
  • Zachary, I., P. Woll, and E. Rozengurt, 1987. A role for neuropeptides in the control of cell proliferation. Developmental Biology, 124(2): p. 295-308.
  • Steiner, D.F., 1998. The proprotein convertases. Curr Opin Chem Biol, 2(1): p. 31-9.
  • Dhanvantari, S., F.-S. Shen, T. Adams, C.R. Snell, C. Zhang, R.B. Mackin, S.J. Morris, and Y.P. Loh, 2003. Disruption of a Receptor-Mediated Mechanism for Intracellular Sorting of Proinsulin in Familial Hyperproinsulinemia. Mol Endocrinol, 17(9): p. 1856-1867.
  • Yanik, T., G. Dominguez, M.J. Kuhar, E.M. Del Giudice, and Y.P. Loh, 2006. The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology, 147(1): p. 39-43.
  • Egan, M.F., M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, E. Zaitsev, B. Gold, D. Goldman, M. Dean, B. Lu, and D.R. Weinberger, 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2): p. 257-69.
  • Woo, N.H., H.K. Teng, C.J. Siao, C. Chiaruttini, P.T. Pang, T.A. Milner, B.L. Hempstead, and B. Lu, 2005. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci, 8(8): p. 1069-77.
  • Lee, R., P. Kermani, K.K. Teng, and B.L. Hempstead, 2001. Regulation of cell survival by secreted proneurotrophins. Science, 294(5548): p. 1945-8.
  • Fricker, L.D. and S.H. Snyder, 1983. Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. J. Biol. Chem., 258(18): p. 10950-5.
  • Hook, V.Y.H. and Y.P. Loh, 1984. Carboxypeptidase B-like converting enzyme activity in secretory granules of rat pituitary. Proc. Natl. Acad. Sci. USA, 81: p. 2776-2780.
  • Cool, D.R., E. Normant, F.-S. Shen, H.-C. Chen, L. Pannell, Y. Zhang, and Y.P. Loh, 1997. Carboxypeptidase E is a regulated secretory pathway sorting receptor: Genetic obliteration leads to endocrine disorders in Cpef at mice. Cell, 88(1): p. 73-83.
  • Lou, H., S.-K. Kim, E. Zaitsev, C.R. Snell, B. Lu, and Y.P. Loh, 2005. Sorting and Activity-Dependent Secretion of BDNF Require Interaction of a Specific Motif with the Sorting Receptor Carboxypeptidase E. Neuron, 45(2): p. 245-255.
  • Park, J.J., N.X. Cawley, and Y.P. Loh, 2008. A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons. Mol Cell Neurosci, 39(1): p. 63-73.
  • Park, J.J., N.X. Cawley, and Y.P. Loh, 2008. Carboxypeptidase E cytoplasmic tail-driven vesicle transport is key for activity-dependent secretion of peptide hormones. Mol Endocrinol, 22(4): p. 989-1005.
  • Cawley, N.X., J. Zhou, J.M. Hill, D. Abebe, S. Romboz, T. Yanik, R.M. Rodriguiz, W.C. Wetsel, and Y.P. Loh, 2004. The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology, 145(12): p. 5807-19.
  • Zhu, X., K. Wu, L. Rife, N.X. Cawley, B. Brown, T. Adams, K. Teofilo, C. Lillo, D.S. Williams, Y.P. Loh, and C.M. Craft, 2005. Carboxypeptidase E is required for normal synaptic transmission from photoreceptors to the inner retina. J Neurochem, 95: p. 1351-1362.
  • Jacob, T.C. and J.M. Kaplan, 2003. The EGL-21 carboxypeptidase E facilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions. J Neurosci, 23(6): p. 2122-30.
  • Naggert, J.K., L.D. Fricker, O. Varlamov, P.M. Nishina, Y. Rouille, D.F. Steiner, R.J. Carroll, B.J. Paigen, and E.H. Leiter, 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet, 10(2): p. 135-42.
  • Varlamov, O., E.H. Leiter, and L. Fricker, 1996. Induced and spontaneous mutations at Ser202 of carboxypeptidase E. Effect on enzyme expression, activity, and intracellular routing. J Biol Chem, 271(24): p. 13981-6.
  • Cawley, N.X., Y.M. Rodriguez, A. Maldonado, and Y.P. Loh, 2003. Trafficking of mutant carboxypeptidase E to secretory granules in a beta-cell line derived from Cpe(fat)/Cpe(fat) mice. Endocrinology, 144(1): p. 292-8.
  • Jin, K., S.H. Graham, T. Nagayama, P.C. Goldsmith, D.A. Greenberg, A. Zhou, and R.P. Simon, 2001. Altered expression of the neuropeptide-processing enzyme carboxypeptidase E in the rat brain after global ischemia. J Cereb Blood Flow Metab, 21(12): p. 1422-9.
  • Utsunomiya, N., S. Ohagi, T. Sanke, H. Tatsuta, T. Hanabusa, and K. Nanjo, 1998. Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity. Diabetologia, 41(6): p. 701-5.
  • Chen, H., S. Jawahar, Y. Qian, Q. Duong, G. Chan, A. Parker, J.M. Meyer, K.J. Moore, S. Chayen, D.J. Gross, B. Glaser, M.A. Permutt, and L.D. Fricker, 2001. Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat, 18(2): p. 120-31.
  • Jia, E.Z., J. Wang, Z.J. Yang, T.B. Zhu, L.S. Wang, H. Wang, C.J. Li, B. Chen, K.J. Cao, J. Huang, and W.Z. Ma, 2007. Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis. Mol Biol Rep.
  • Jia, E.Z., J. Wang, Z.J. Yang, T.B. Zhu, L.S. Wang, B. Chen, K.J. Cao, J. Huang, and W.Z. Ma, 2008. Molecular scanning of the human carboxypeptidase E gene for mutations in Chinese subjects with coronary atherosclerosis. Mol Cell Biochem, 307(1-2): p. 31-9.
  • Wang, J., Y. Zhang, Z.J. Yang, T.B. Zhu, L.S. Wang, B. Chen, K.J. Cao, J. Huang, W.Z. Ma, and E.Z. Jia, 2008. Association of human carboxypeptidase E exon5 gene polymorphisms with angiographical characteristics of coronary atherosclerosis in a Chinese population. Acta Pharmacol Sin, 29(6): p. 736-44.
  • Ambrose, C.M., M.P. Duyao, G. Barnes, G.P. Bates, C.S. Lin, J. Srinidhi, S. Baxendale, H. Hummerich, H. Lehrach, M. Altherr, and et al., 1994. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet, 20(1): p. 27-38.
  • Dragatsis, I., P. Dietrich, and S. Zeitlin, 2000. Expression of the Huntingtin-associated protein 1 gene in the developing and adult mouse. Neurosci Lett, 282(1-2): p. 37-40.
  • Perutz, M.F., T. Johnson, M. Suzuki, and J.T. Finch, 1994. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A, 91(12): p. 5355-8.
  • Scherzinger, E., R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker, 1997. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell, 90(3): p. 549-58.
  • Gomis-Ruth, F.X., V. Companys, Y. Qian, L.D. Fricker, J. Vendrell, F.X. Aviles, and M. Coll, 1999. Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily. Embo J, 18(21): p. 5817-26.
  • Dhanvantari, S., I. Arnaoutova, C.R. Snell, P.J. Steinbach, K. Hammond, G.A. Caputo, E. London, and Y.P. Loh, 2002. Carboxypeptidase E, a prohormone sorting receptor, is anchored to secretory granules via a C-terminal transmembrane insertion. Biochemistry, 41(1): p. 52-60.
  • Zhang, C.-F., S. Dhanvantari, H. Lou, and Y.P. Loh, 2003. Sorting of carboxypeptidase E to the regulated secretory pathway requires interaction of its transmembrane domain with lipid rafts. Biochem J, 369(Pt 3): p. 453-60.
  • Dhanvantari, S. and Y.P. Loh, 2000. Lipid raft association of carboxypeptidase E is necessary for its function as a regulated secretory pathway sorting receptor. J Biol Chem, 275(38): p. 29887-93.
  • Fricker, L.D., B. Das, and R.H. Angeletti, 1990. Identification of the pH-dependent membrane anchor of carboxypeptidase E (EC 3.4.17.10). J Biol Chem, 265(5): p. 2476-82.
  • Parkinson, D., 1990. Two soluble forms of bovine carboxypeptidase H have different NH2-terminal sequences. J Biol Chem, 265(28): p. 17101-5.
  • Lou, H., A.M. Smith, L.C. Coates, N.X. Cawley, Y.P. Loh, and N.P. Birch, 2007. The transmembrane domain of the prohormone convertase PC3: a key motif for targeting to the regulated secretory pathway. Mol Cell Endocrinol, 267(1-2): p. 17-25.
  • Kristin D. Jeffrey, Emilyn U. Alejandro, Dan S. Luciani, Tatyana B. Kalynyak, Xiaoke Hu, Hong Li, Yalin Lin, R. Reid Townsend, Kenneth S. Polonsky, and James D. Johnson Carboxypeptidase E mediates palmitate-induced β-cell ER stress and apoptoz 2008. Proc Natl Acad Sci U S A. June 17; 105(24): 8452–8457.
  • Stephen O'Rahilly and I.Sadaf Farooqi 2006. Genetics of obesity Philos Trans R Soc Lond B Biol Sci. 361(1471): 1095–1105.
  • Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006. Jan;16(1):55-65.
  • Heping Zhang, Shupeng Li, Min Wang, Brian Vukusic, Zdenek B Pristupa, and Fang Liu. 2009. Regulation of dopamine transporter activity by carboxypeptidase E Mol Brain.; 2: 10.
  • Cawley NX, Yanik T, Woronowicz A, Chang W, Marini JC, Loh YP. 2010. Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. Am J Physiol Endocrinol Metab. Aug;299 (2):E189-97.50
  • Caruso C, Sanchez M, Durand D, de la Cruz Perez M, Gonzalez PV, Lasaga M, Scimonelli TN. 2010 alpha-Melanocyte-stimulating hormone modulates lipopolysaccharide plus interferon-gamma-induced tumor necrosis factor-alpha expression but not tumor necrosis factor-alpha receptor expression in cultured hypothalamic neurons. J Neuroimmunol. Jul 7. [Epub ahead of print] PubMed PMID: 20619468.
  • Chunyan Xu, Beatrice Bailly-Maitre, and John C. Reed 2005 Endoplasmic reticulum stress:cell life and death decisions The Journal of Clinical Investigation 115:2656-2664
  • Koshimizu H, Senatorov V, Loh YP, Gozes I. 2009 Neuroprotective protein and carboxypeptidase E. J Mol Neurosci. Sep;39(1-2):1-8. Epub 2009 Jan 23. Review.
  • Lee KP et al. 2008 Cell 132:89-100
  • Boya P and Kroemer, GK 2008 Lysosomal membrane permeability in cell death. Oncogene 27: 6434–6451
  • Plá V, Paco S, Ghezali G, Ciria V, Pozas E, Ferrer I, Aguado F. 2013 Secretory sorting receptors carboxypeptidase E and secretogranin III in amyloid β-associated neural degeneration in Alzheimer's disease. Brain Pathol. 23(3):274-84. doi: 10.1111/j.1750- 3639.2012.00644.x. PMID: 22998035.
  • Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, Loh YP. New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev. 2012 Apr;33(2):216-53. doi: 10.1210/er.2011-1039. Epub 2012 Mar 7. Review. PubMed PMID: 22402194; PubMed Central PMCID: PMC3365851.
  • Koshimizu H, Senatorov V, Loh YP, Gozes I 2009 Neuroprotective protein and carboxypeptidase E. J Mol Neurosci 39:1–8
  • Cheng Y, Cawley NX, Yanik T, Liu C, Murthy S, Loh Y 2011 Carboxypeptidase E in neuroprotection: links to neurodegeneration and Alzheimer's disease. Program of 41st Annual Meeting of the Society for Neuroscience, Washington, D.C., (Abstract 48.01/O11)
  • Kasikci F, Cawley,NX, Yanik T, Loh P (2013) Investigation Of The Cellular Mechanisms Underlying the Carboxypeptidase E Mutation Special Issue: 38th FEBS Congress, Saint Petersburg, Russia, July 6–11, 2013 Volume 280, Issue Supplement s1 Pages 1–661
APA YANIK T (2013). Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. , 1 - 35.
Chicago YANIK Tülay Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. (2013): 1 - 35.
MLA YANIK Tülay Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. , 2013, ss.1 - 35.
AMA YANIK T Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. . 2013; 1 - 35.
Vancouver YANIK T Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. . 2013; 1 - 35.
IEEE YANIK T "Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi." , ss.1 - 35, 2013.
ISNAD YANIK, Tülay. "Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi". (2013), 1-35.
APA YANIK T (2013). Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. , 1 - 35.
Chicago YANIK Tülay Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. (2013): 1 - 35.
MLA YANIK Tülay Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. , 2013, ss.1 - 35.
AMA YANIK T Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. . 2013; 1 - 35.
Vancouver YANIK T Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi. . 2013; 1 - 35.
IEEE YANIK T "Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi." , ss.1 - 35, 2013.
ISNAD YANIK, Tülay. "Karboksipeptidaz e'nin nöroproteksiyondaki rolünün hücresel mekanizmalarının incelenmesi". (2013), 1-35.
Sayfa Oluşturulma Tarihi
26-03-2024 6:54

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları